脳萎縮症の英語

強力な非ＮＭＤＡ拮抗特性を有し、脳血管発作、脳または脊髄の外傷、癩癇、アルツハイマー病などの慢性神経変性疾患、精神分裂病、筋萎縮性側索硬化症またはハンチントン舞踏病の治療に有用で腎毒性が低い新規化合物の提供。例文帳に追加

To obtain a novel compound that has strong non-NMD antagonistic properties, is useful for treatment of cerebral blood vessel attack, external wound in brain and vertebra, epilepsy, chromatic neurodegenerative diseases, for example, Alzheimer's disease, schizophrenia, amyotrophic lateral sclerosis or Huntington's chorea with reduced nephrotoxicity. - 特許庁

さらに、疾病が精神疾患（アルツハイマー病、パーキンソン病、老人性痴呆、多発性硬化症、筋萎縮性側索硬化症(ALS)、癲癇、自律神経機能疾患、睡眠障害、精神神経性疾患、うつ病、精神分裂症、躁病、不安症疾患、恐怖症疾患、学習障害、記憶障害、健忘症、加齢に関連した記憶喪失、不安症、片頭痛、外傷性脳傷害、または神経損傷など）である。例文帳に追加

Further, the diseases include neurological disorders (Alzheimer's disease, Parkinson's disease, senile dementia, multiple sclerosis, amyotrophic lateral sclerosis (ALS), epilepsy, autonomic function disorder, sleep disorder, neuropsychiatric disorder, depression, schizophrenia, mania, anxiety disorder, phobic disorder, learning disorder, memory disorder, amnesia, age-related memory loss, anxiety, migraine, traumatic brain injury, nerve damage and the like). - 特許庁

筋ジストロフィー、筋萎縮症、心筋梗塞、脳卒中、アルツハイマー病、頭部外傷時の意識障害や運動障害、多発性硬化症、末梢神経のニューロパシー、炎症、アレルギー、劇症肝炎、高カルシウム血症、乳癌、前立腺癌、前立腺肥大、骨粗鬆症などの治療薬として有用なカルパイン阻害活性を有する化合物を提供することである。例文帳に追加

To obtain a compound having a calpain inhibitory activity and useful as a therapeutic agent for muscular dystrophy, amyotrophy, cardiac infarction, cerebral apoplexy, Alzheimer's disease, disturbance of consciousness or dyskinesia during head trauma, multiple sclerosis, neuropathy of peripheral nerve, inflammations, allergies, fulminant hapatitis, hypercalcemia, mammary cancer, prostatic cancer, prostatomegaly, osteoporosis or the like. - 特許庁

パーキンソン病、ハンチントン病、アルツハイマー病、脊髄小脳萎縮、トゥーレット症候群、フリードライヒ失調、マシャド・ジョセフ病、レビー小体痴呆、ジストニア、進行性核上性麻痺、又は前頭側頭型痴呆等の神経変性疾患の治療薬の提供。例文帳に追加

To provide therapeutics for treating neurodegenerative diseases including Parkinson's disease, Huntington's disease, Alzheimer's disease, spinocerebellar atrophy, Tourette syndrome, Friedreich ataxia, Machado-Joseph disease, dementia with Lewy bodies, dystonia, progressive supranuclear palsy, frontotemporal dementia, etc. - 特許庁

疼痛、UI、潰瘍、IBD、IBS、依存性障害、パーキンソン病、パーキンソン症候群、不安症、癲癇、発作、痙攣、そう痒性症状、精神病、認知障害、記憶欠乏、制限性脳機能、ハンティングトン舞踏病、筋萎縮性側索硬化、痴呆、網膜症、筋痙攣、偏頭痛、嘔吐、運動異常または抑うつを治療または予防する方法の提供。例文帳に追加

To provide a method for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, cognitive impairment, memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia or depression. - 特許庁

強力な非ＮＭＤＡアンタゴニスト性を有し、脳血管障害のような変性障害、脳性若しくは脊髄性外傷、てんかん、アルツハイマー病のような慢性神経変性疾患、精神分裂症、筋萎縮性側索硬化症又はハンチントン舞踏病の、急性治療、及び特に慢性治療に有用な新規な化合物の提供。例文帳に追加

To provide a new compound which has a strong non-NMDA antagonist property, and is useful for the acute and especially chronic treatments of degenerative disorders such as cerebrovascular disorder, chronic neurodegenerative disorders such as cerebral or spinal trauma, epilepsy and Alzheimer's disease, schizophrenia, amyotrophic lateral sclerosis and Huntington's chorea. - 特許庁

治療的に有効な量のＦＴＹ７２０化合物を被験体に投与する工程を包含する、神経障害（パーキンソン病、振せん麻痺障害、ハンティングトン病、アルツハイマー病、筋萎縮性側索硬化症、脊髄虚血、虚血性脳卒中、脊髄損傷、癌関連脳損傷、癌関連脊髄損傷およびシャイ−ドレーガー症候群など）の予防または処置のための方法もまた開示される。例文帳に追加

There is also provided a method for preventing or treating neurological disorders, including Parkinson's disease, paralysis agitans, Huntington's disease, Alzheimer's disease, amyotrophic lateral sclerosis, spinal cord ischaemia, ischemic stroke, spinal cord injury, brain damage associated with cancer, spinal cord injury associated with cancer, and Shy-Drager syndrome, or the like, comprising a step of administering to a subject a therapeutically effective amount of a FTY720 compound. - 特許庁

ＥＰ_４アゴニストは、興奮性アミノ酸誘発神経細胞死保護作用を有するので、神経変性疾患（例えば、パーキンソン病、パーキンソン症候群、アルツハイマー病、認知症、筋萎縮性側索硬化症または脳卒中等）の予防、治療および／または進展抑制、または神経細胞保護に有用である。例文帳に追加

EP_4 agonist has an action to protect the death of neurocyte induced by exciting amino acid and, accordingly, is useful for the prevention, treatment and/or progress suppression of neurodegenerative diseases (for example, Parkinson's disease, Parkinson syndrome, Alzheimer's disease, dementia, amyotrophic lateral sclerosis and cerebral apoplexy) or the protection of neurocyte. - 特許庁